A. Barrish

In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α_1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia

James C. Barrow, Philippe G. Nantermet, Harold G. Selnick et al. · Journal of Medicinal Chemistry · 2000 · 220 citations · Full text

Molecular Pharmacology, Urology, Pharmacological Study +12

Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE®) once daily versus timolol maleate ophthalmic solution twice daily

Arthur Shedden, Jean Laurence, A. Barrish et al. · Documenta Ophthalmologica · 2001 · 57 citations

Determination of L-654,066, a new 5α-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry

John D. Gilbert, Timothy Olah, A. Barrish et al. · Journal of Mass Spectrometry · 1992 · 49 citations

Aldo-keto Reductase, New 5α-Reductase Inhibitor, Alpha-reductase Inhibitor +19

Determination of the β-adrenergic blocker timolol in plasma by liquid chromatography—atmospheric pressure chemical ionization mass spectrometry

Timothy Olah, John D. Gilbert, A. Barrish · Journal of Pharmaceutical and Biomedical Analysis · 1993 · 27 citations

Adrenal Gland, Gas Chromatography, Medicine +9

Non-peptide αvβ3 antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl β-amino acids as aspartic acid replacements

Karen M. Brashear, C. A. HUNT, Brian T Kucer et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 26 citations · Full text

Biochemistry, Medicine, Peptide Engineering +11